Kidney Stone Disease: An Update on Current Concepts.

Alelign T, Petros B. · 2018

Read Kidney Stone Disease: An Update on Current Concepts. by Alelign T, Petros B. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5817324.txt.

Introduction

Alelign and Petros update current thinking on kidney stone disease. Stones are hard crystal masses that form in the kidneys. The disorder affects about 12 percent of the world population. It also raises the risk of kidney failure.

The review covers causes, stone types, and how stones form. Calcium oxalate stones are the most common kind. Formation runs through saturation, nucleation, growth, and clumping of crystals. Cell injury helps crystals stick to kidney surfaces. No drug yet cures or prevents repeat stones well. The authors point to prevention paths that need study. Readers get a full primer on a painful, rising disorder.

Catalog record

CREATORAlelign T, Petros B.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5817324

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Kidney Stone Disease: An Update on Current Concepts By Tilahun Alelign, Beyene Petros Published in: Advances in Urology DOI: 10.1155/2018/3068365 ABSTRACT Abstract Kidney stone disease is a crystal concretion formed usually within the kidneys. It is an increasing urological disorder of human health, affecting about 12% of the world population. It has been associated with an increased risk of end-stage renal failure. The etiology of kidney stone is multifactorial. The most common type of kidney stone is calcium oxalate formed at Randall's plaque on the renal papillary surfaces. The mechanism of stone formation is a complex process which results from several physicochemical events including supersaturation, nucleation, growth, aggregation, and retention of urinary stone constituents within tubular cells. These steps are modulated by an imbalance between factors that promote or inhibit urinary crystallization. It is also noted that cellular injury promotes retention of particles on renal papillary surfaces. The exposure of renal epithelial cells to oxalate causes a signaling cascade which leads to apoptosis by p38 mitogen-activated protein kinase pathways. Currently, there is no satisfactory drug to cure and/or prevent kidney stone recurrences. Thus, further understanding of the pathophysiology of kidney stone formation is a research area to manage urolithiasis using new drugs. Therefore, this review has intended to provide a compiled up-to-date information on kidney stone etiology, pathogenesis, and prevention approaches. 1. INTRODUCTION 1.1. Overview of Kidney Stones Kidney stones are mainly lodged in the kidney(s) [1]. Mankind has been afflicted by urinary stones since centuries dating back to 4000 B.C. [2], and it is the most common disease of the urinary tract. The prevention of renal stone recurrence remains to be a serious problem in human health [3]. The prevention of stone recurrence requires better understanding of the mechanisms involved in stone formation [4]. Kidney stones have been associated with an increased risk of chronic kidney diseases [5], end-stage renal failure [3, 6], cardiovascular diseases [7, 8], diabetes, and hypertension [9]. It has been suggested that kidney stone may be a systemic disorder linked to the metabolic syndrome. Nephrolithiasis is responsible for 2 to 3% of end-stage renal cases if it is associated with nephrocalcinosis [10]. The symptoms of kidney stone are related to their location whether it is in the kidney, ureter, or urinary bladder [11]. Initially, stone formation does not cause any symptom. Later, signs and symptoms of the stone disease consist of renal colic (intense cramping pain), flank pain (pain in the back side), hematuria (bloody urine), obstructive uropathy (urinary tract disease), urinary tract infections, blockage of urine flow, and hydronephrosis (dilation of the kidney). These conditions may result in nausea and vomiting with associated suffering from the stone event [12]. Thus, the treatment and time lost from work involves substantial cost imposing an impact on the quality of life and nation's economy. 1.2. Epidemiology of Kidney Stones Globally, kidney stone disease prevalence and recurrence rates are increasing [13], with limited options of effective drugs. Urolithiasis affects about 12% of the world population at some stage in their lifetime [14]. It affects all ages, sexes, and races [15, 16] but occurs more frequently in men than in women within the age of 20–49 years [17]. If patients do not apply metaphylaxis, the relapsing rate of secondary stone formations is estimated to be 10–23% per year, 50% in 5–10 years, and 75% in 20 years of the patient [15]. However, lifetime recurrence rate is higher in males, although the incidence of nephrolithiasis is growing among females [18]. Therefore, prophylactic management is of great importance to manage urolithiasis. Recent studies have reported that the prevalence of urolithiasis has been increasing in the past decades in both developed and developing countries. This growing trend is believed to be associated with changes in lifestyle modifications such as lack of physical activity and dietary habits [19–21] and global warming [16]. In the United States, kidney stone affects 1 in 11 people [22], and it is estimated that 600,000 Americans suffer from urinary stones every year. In Indian population, about 12% of them are expected to have urinary stones and out of which 50% may end up with loss of kidney functions [23]. 2. THE URINARY SYSTEM AND STONES The urinary filtrate is formed in the glomerulus and passes into the tubules where the volume and content are altered by reabsorption or secretions. Most solute reabsorption occurs in the proximal tubules, whereas fine adjustments to urine composition take place in the distal tubule and collecting ducts. The loop of Henle serves to concentrate urine composed of 95% water, 2.5% urea, 2.5% mixture of minerals, salts, hormones, and enzymes. In the proximal tubules, glucose, sodium, chloride, and water are reabsorbed and returned to the blood stream along with essential nutrients such as amino acids, proteins, bicarbonate, calcium, phosphate, and potassium. In the distal tubule, the salt and acid-base balance of blood is regulated [24]. The location of stones may vary as indicated in Figure 1. [Figure: Kidney stone locations in the urinary system. (a) Adopted from [25]. (b) Adopted from [26].] 3. TYPES OF KIDNEY STONES The chemical composition of kidney stones depends on the abnormalities in urine composition of various chemicals. Stones differ in size, shape, and chemical compositions (mineralogy) [27]. Based on variations in mineral composition and pathogenesis, kidney stones are commonly classified into five types as follows [28]. 3.1. Calcium Stones: Calcium Oxalate and Calcium Phosphate Calcium stones are predominant renal stones comprising about 80% of all urinary calculi [29]. The proportion of calcium stones may account for pure calcium oxalate (CaOx) (50%), calcium phosphate (CaP, termed as apatite) (5%), and a mixture of both (45%) [30]. The main constituent of calcium stones is brushite (calcium hydrogen phosphate) or hydroxyapatite [31, 32]. Calcium oxalate is found in the majority of kidney stones and exists in the form of CaOx monohydrate (COM, termed as mineral names: whewellite, CaC2O4·H2O), and CaOx dihydrate (COD, weddellite, CaC2O4·2H2O), or as a combination of both which accounts for greater than 60% [33]. COM is the most thermodynamically stable form of stone. COM is more frequently observed than COD in clinical stones [34]. Many factors contribute to CaOx stone formation such as hypercalciuria (resorptive, renal leak, absorptive, and metabolic diseases), hyperuricosuria, hyperoxaluria, hypocitraturia, hypomagnesuria, and hypercystinuria [35]. Mostly, urinary pH of 5.0 to 6.5 promotes CaOx stones [36], whereas calcium phosphate stones occur when pH is greater than 7.5 [11]. The recurrence of calcium stone is greater than other types of kidney stones. 3.2. Struvite or Magnesium Ammonium Phosphate Stones Struvite stones occur to the extent of 10–15% and have also been referred to as infection stones and triple phosphate stones. It occurs among patients with chronic urinary tract infections that produce urease, the most common being Proteus mirabilis and less common pathogens include Klebsiella pneumonia, Pseudomonas aeruginosa, and Enterobacter [1, 28, 29]. Urease is necessary to split/cleave urea to ammonia and CO2, making urine more alkaline which elevates pH (typically > 7). Phosphate is less soluble at alkaline versus acidic pH, so phosphate precipitates on to the insoluble ammonium products, yielding to a large staghorn stone formation [37]. Women's are likely to develop this type of stone than the male. Escherichia coli is not capable of

Read the complete text